Neuroprotective effect of nicorandil through inhibition of apoptosis by the PI3K/Akt1 pathway in a mouse model of deep hypothermic low flow

J Neurol Sci. 2015 Oct 15;357(1-2):119-25. doi: 10.1016/j.jns.2015.07.010. Epub 2015 Jul 9.

Abstract

Objective: Nicorandil exerts a protective effect on ischemia-reperfusion (I/R) injury in the brain and kidney through anti-apoptotic mechanisms. However, the mechanism by which nicorandil protects against I/R injury induced by deep hypothermic low flow (DHLF) remains unclear.

Methods: We used a cerebral I/R model induced by DHLF to determine the neuroprotective effects and possible mechanisms of nicorandil.

Results: Hematoxylin-eosin (HE) staining and in situ terminal deoxynucleotidyl transferase UTP nick end labeling (TUNEL) assay were used to detect changes in cell morphology and the number of apoptotic cells in hippocampus, respectively. The apoptotic regulators including Bcl-2, Bax, Akt, and p-Akt (the active, phosphorylated form of Akt) were examined by Western blot (WB). Histopathological findings showed that nicorandil significantly alleviated morphological damage in hippocampal and reduced the number of TUNEL-positive nuclei induced by DHLF. Nicorandil also increased the expression of Bcl-2 and decreased the expression of Bax, while increasing p-Akt level. Consistent with these results, nicorandil-mediated neuroprotection was reduced in the Akt1+/- mutant mice and inhibited by LY294002, a PI3K inhibitor.

Conclusions: These findings showed that nicorandil provides a neuroprotective role in DHLF-induced I/R injury by inhibiting apoptosis via activation of the PI3K/Akt1 signaling pathway.

Keywords: Apoptosis; Deep hypothermic low flow; Neuroprotection; Nicorandil; PI3K/Akt.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Chromones / pharmacology
  • Circulatory Arrest, Deep Hypothermia Induced / adverse effects*
  • Disease Models, Animal
  • Down-Regulation / drug effects
  • Mice
  • Morpholines / pharmacology
  • Neuroprotective Agents / antagonists & inhibitors
  • Neuroprotective Agents / pharmacology*
  • Neuroprotective Agents / therapeutic use
  • Nicorandil / antagonists & inhibitors
  • Nicorandil / pharmacology*
  • Nicorandil / therapeutic use
  • Phosphatidylinositol 3-Kinases / metabolism*
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Proto-Oncogene Proteins c-bcl-2 / biosynthesis
  • Reperfusion Injury / drug therapy
  • Signal Transduction / drug effects*
  • Up-Regulation / drug effects
  • bcl-2-Associated X Protein / biosynthesis

Substances

  • Chromones
  • Morpholines
  • Neuroprotective Agents
  • Proto-Oncogene Proteins c-bcl-2
  • bcl-2-Associated X Protein
  • Nicorandil
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt